Electroacupuncture at Zusanli ( ST36 ) Alleviate Intestinal Ischemia‐Reperfusion Injury by Regulating the Cholinergic‐ miRNA 124 Pathway
Neurogastroenterology & Motility · 2026
DOI: 10.1111/nmo.14971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, 2026. Verfasst von YanXia Geng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, …. Hauptthemen laut MEDLINE: Reperfusion Injury, Electroacupuncture, MicroRNAs, Intestines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Construction Project of National Famous Chinese Medicine Experts, Prof. Zhou Min's Research Office.
Abstract (Originalsprache)
Objective
Intestinal ischemia‐reperfusion injury (IIRI) is common in a variety of critical diseases and acute stress, and acupuncture is a promising treatment for IIRI. The aim of this study is to explore the mechanism of electroacupuncture (EA) at Zusanli (ST36) in improving IIRI from the perspective of the cholinergic anti‐inflammatory pathway (CAP) and miRNA 124.
Methods
Seven groups of mice were performed: Control group, I/R group (IIRI model), EA group (I/R + EA), miRNA mimic group (I/R + EA + miRNA 124 mimic), miRNA inhibitor group (I/R + EA + miRNA 124 inhibitor), PNU group (I/R + EA + α7nAChR agonist), and MLA group (I/R + EA+ α7nAChR antagonist). The expression of intestinal macrophages, α7nAChR, miRNA 124, and related molecules, including p‐STAT3 and IL‐6, as well as histological damage (Chiu's score) and mucosal permeability (serum FD4 concentration), were detected.
Results
The serum FD4 concentrations in the EA and PNU groups were significantly lower compared to the I/R group ( p < 0.05). The expression of intestinal α7nAChR and miRNA 124 in the EA, miRNA mimic, and PNU groups was higher than that in the I/R group ( p < 0.05), while levels of p‐STAT3 and IL‐6 were reduced ( p < 0.05). Conversely, in the miRNA inhibitor and MLA groups, miRNA 124 levels were significantly lower than in the EA group ( p < 0.05), and IL‐6 levels were increased ( p < 0.05).
Conclusion
EA at Zusanli may induce miRNA124 through the cholinergic pathway on intestinal macrophages, which may be a key neuro‐immune target of EA in the treatment of IIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
- Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- Department of Acupuncture and Rehabilitation, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
ORCID-Profile: YanXia Geng
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Construction Project of National Famous Chinese Medicine Experts, Prof. Zhou Min's Research Office
Zitieren
APA
Geng, Y., Lv, H., Liu, Y., Guo, D., Zheng, J., Li, Y., Jiang, H., & Chen, D. (2026). Electroacupuncture at Zusanli ( ST36 ) Alleviate Intestinal Ischemia‐Reperfusion Injury by Regulating the Cholinergic‐ miRNA 124 Pathway. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14971
Vancouver
Geng Y, Lv H, Liu Y, Guo D, Zheng J, Li Y, et al. Electroacupuncture at Zusanli ( ST36 ) Alleviate Intestinal Ischemia‐Reperfusion Injury by Regulating the Cholinergic‐ miRNA 124 Pathway. Neurogastroenterology & Motility. 2026. doi:10.1111/nmo.14971
BibTeX
@article{Geng2026,
author = {Geng, YanXia and Lv, Hai and Liu, Yu and Guo, DingDing and Zheng, JingJing and Li, YingXin and Jiang, Hua and Chen, Dong},
title = {Electroacupuncture at Zusanli ( ST36 ) Alleviate Intestinal Ischemia‐Reperfusion Injury by Regulating the Cholinergic‐ miRNA 124 Pathway},
journal = {Neurogastroenterology & Motility},
year = {2026},
doi = {10.1111/nmo.14971}
}
EUVIMED